Recent Company News

• 04:05 AM ET Feb 09, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (137 total)

• 04:04 AM ET Feb 03, 2026
  

  Bayer AG's Nubeqa (darolutamide) receives third approval in China for men with advanced prostate cancer (€45.51, +0.50)

• 01:28 AM ET Jan 30, 2026
  

  Orion downgraded to hold from buy at Jefferies (€70.15, 0.00)

• 03:56 AM ET Jan 28, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (175 total)

• 03:40 PM ET Jan 19, 2026
  

  Hyloris Pharmaceuticals enters into exclusive license and supply agreement with Orion for Pantoprazole IV in E.U., UK, Switzerland and Norway (€7.62, 0.00)

• 04:25 AM ET Jan 15, 2026
  

  Orion downgraded to accumulate from buy at OP Corporate Bank (pre-European open) (€71.50, +1.20)

• 04:15 AM ET Jan 15, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (131 total)

• 06:44 AM ET Jan 14, 2026
  

  Healthcare, utilities, basic resources and chemicals the best performers; media, travel/leisure, tech and retail lag:

• 04:06 AM ET Jan 14, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:48 AM ET Jan 14, 2026
  

  StreetAccount Summary - European pre-market trading update